PDGF receptor tyrosine kinase inhibitor IV   Click here for help

GtoPdb Ligand ID: 6020

Synonyms: JNJ-10198409
Compound class: Synthetic organic
Comment: This is compound 17 in [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 59.17
Molecular weight 325.12
XLogP 3.69
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc2c(cc1OC)Cc1c2[nH]nc1Nc1cccc(c1)F
Isomeric SMILES COc1cc2c(cc1OC)Cc1c2[nH]nc1Nc1cccc(c1)F
InChI InChI=1S/C18H16FN3O2/c1-23-15-7-10-6-14-17(13(10)9-16(15)24-2)21-22-18(14)20-12-5-3-4-11(19)8-12/h3-5,7-9H,6H2,1-2H3,(H2,20,21,22)
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Biochem J, 451 (2): 313-28. [PMID:23398362]
3. Ho CY, Ludovici DW, Maharoof US, Mei J, Sechler JL, Tuman RW, Strobel ED, Andraka L, Yen HK, Leo G et al.. (2005)
(6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells.
J Med Chem, 48 (26): 8163-73. [PMID:16366598]